黑料网

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Effectiveness and safety of Wuling capsule for post stroke depression: A systematic review

2nd International Summit on Clinical Pharmacy

Le Peng, De-ying Kang,, Xin Zhang, Xue-ting Liu and Qi Hong

ScientificTracks Abstracts: Clinic Pharmacol Biopharm

DOI:

Abstract
Objective: To review the effectiveness and safety of Wuling capsule for post stroke depression (PSD) systematically. Methods: We searched electronic databases for randomized controlled trials (RCTs) that compared either Wuling capsule with placebo, no treatment or Wuling capsule plus conventional treatment with conventional treatment alone in adults with post stroke depression. Relevant resources were also retrieved. Two reviewers screened the citations, assessed the risk of bias and extracted data independently. Results: A total of 16 studies involving 1378 patients were identified for this review. There were 3 trials comparing Wuling capsule with no treatment control and 13 trials comparing Wuling capsule plus conventional treatment (Deanxit, Fluoxetine, Sertraline, Paroxetine or Citalopram) with conventional treatment alone. Meta-analyses indicated Wuling capsule used alone or integrated with conventional treatment was effective for PSD in terms of HAMD (Hamilton depression scale) scores, response rate and with less adverse effects, of which, HAMD scores decreased significantly in favor of Wuling capsule from onset time to 1 week (SMD=1.27, 95%CI: 0.71~1.83, P<0.00001), 2 weeks (SMD=1.45, 95%CI: 0.57~2.33, P=0.001), 4 weeks (SMD=2.84, 95%CI:2.15~3.52, P<0.00001), 6 weeks (SMD=2.70, 95%CI: 2.15~3.24, P<0.00001), and 8 weeks (SMD=4.53, 95% CI:3.55~5.50, P<0.00001) and overall effect (SMD=2.40, 95% CI:1.75~3.05, P<0.00001)(SMD=standardized mean difference). Conclusion: Wuling capsule appeared to present certain antidepressant effect compared to no treatment control. With a combination of several Western medicines, Wuling capsule could be helpful in strengthening efficacy and reducing the incidence of adverse events as an alternative choice in the treatment of PSD. However, due to the limited number of included trials and relatively moderate methodological quality in the majority of studies, further large scale and rigorously designed trials are warranted to confirm the effectiveness and safety of Wuling capsule for post stroke depression.
Biography
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top